AnalystsRudy LiRudy Li's Stock Forecasts
AnalystsRudy Li
Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4385 out of 4923 analysts
Average Return
-9.93%
Win Rate
47%7 out of 15
Risk vs Reward
Poor
Good
Rudy Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +37.41% | $8.26 | $11.35 | 2025-03-18 - 2025-06-30 | Strong Buy |
Prothena Corp Public Ltd CoPRTA | +32.53% | $4.58 | $6.07 | 2025-05-26 - 2025-06-30 | Strong Buy |
Stoke Therapeutics IncSTOK | +22.04% | $9.30 | $11.35 | 2025-02-18 - 2025-06-30 | Strong Buy |
Praxis Precision Medicines IncPRAX | +10.40% | $38.09 | $42.05 | 2025-05-06 - 2025-06-30 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +6.05% | $12.39 | $13.14 | 2025-05-07 - 2025-06-30 | Strong Buy |
Rudy Li Analyst Color
Get additional color on Rudy Li's coverage of popular stocks
Rudy Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | 5 | Strong Buy | $18.00 | +196.54% | Maintains | a month ago |
Bright Minds Biosciences IncDRUG | 2 | Strong Buy | $80.00 | N/A | Maintains | a month ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $55.00 | +75.72% | Maintains | 2 months ago |
Mind Medicine IncMNMD | 3 | Strong Buy | $20.00 | +208.17% | Maintains | 2 months ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | $30.00 | +128.31% | Initiates Coverage On | 2 months ago |
Praxis Precision Medicines IncPRAX | 1 | Strong Buy | $80.00 | +90.25% | Initiates Coverage On | 2 months ago |
Stoke Therapeutics IncSTOK | 3 | Strong Buy | $24.00 | +111.45% | Maintains | 3 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.